The Role of Targeted Therapy in the Management of Sinonasal Malignancies

Lawrence Kashat, Christopher H. Le, Alexander G Chiu

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Cancers develop secondary to genetic and epigenetic changes that provide the cell with a survival advantage that promotes cellular immortality. Malignancy arises when tumors use mechanisms to evade detection and destruction by the immune system. Many malignancies seem to elicit an immune response, yet somehow manage to avoid destruction by the cells of the immune system. Cancers may evade this immune response by numerous mechanisms. Several targeted immune therapies are available that block some of these inhibitory signals and enhance the cell-mediated immune response. Many of these agents hold significant promise for future treatment of sinonasal and ventral skull base malignancies.

Original languageEnglish (US)
Pages (from-to)443-455
Number of pages13
JournalOtolaryngologic Clinics of North America
Volume50
Issue number2
DOIs
StatePublished - Apr 1 2017
Externally publishedYes

Fingerprint

Neoplasms
Immune System
Therapeutics
Skull Base
Epigenomics

Keywords

  • Cell-mediated immunity
  • Head and neck melanoma
  • Head and neck squamous cell carcinoma
  • Immunotherapy
  • Mucosal melanoma
  • Sinonasal malignancy
  • Sinonasal tumors
  • Targeted therapy

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

The Role of Targeted Therapy in the Management of Sinonasal Malignancies. / Kashat, Lawrence; Le, Christopher H.; Chiu, Alexander G.

In: Otolaryngologic Clinics of North America, Vol. 50, No. 2, 01.04.2017, p. 443-455.

Research output: Contribution to journalReview article

@article{7d9a4b2c2e1f4237bbd00b41ef8d71a8,
title = "The Role of Targeted Therapy in the Management of Sinonasal Malignancies",
abstract = "Cancers develop secondary to genetic and epigenetic changes that provide the cell with a survival advantage that promotes cellular immortality. Malignancy arises when tumors use mechanisms to evade detection and destruction by the immune system. Many malignancies seem to elicit an immune response, yet somehow manage to avoid destruction by the cells of the immune system. Cancers may evade this immune response by numerous mechanisms. Several targeted immune therapies are available that block some of these inhibitory signals and enhance the cell-mediated immune response. Many of these agents hold significant promise for future treatment of sinonasal and ventral skull base malignancies.",
keywords = "Cell-mediated immunity, Head and neck melanoma, Head and neck squamous cell carcinoma, Immunotherapy, Mucosal melanoma, Sinonasal malignancy, Sinonasal tumors, Targeted therapy",
author = "Lawrence Kashat and Le, {Christopher H.} and Chiu, {Alexander G}",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.otc.2016.12.016",
language = "English (US)",
volume = "50",
pages = "443--455",
journal = "Otolaryngologic Clinics of North America",
issn = "0030-6665",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - The Role of Targeted Therapy in the Management of Sinonasal Malignancies

AU - Kashat, Lawrence

AU - Le, Christopher H.

AU - Chiu, Alexander G

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Cancers develop secondary to genetic and epigenetic changes that provide the cell with a survival advantage that promotes cellular immortality. Malignancy arises when tumors use mechanisms to evade detection and destruction by the immune system. Many malignancies seem to elicit an immune response, yet somehow manage to avoid destruction by the cells of the immune system. Cancers may evade this immune response by numerous mechanisms. Several targeted immune therapies are available that block some of these inhibitory signals and enhance the cell-mediated immune response. Many of these agents hold significant promise for future treatment of sinonasal and ventral skull base malignancies.

AB - Cancers develop secondary to genetic and epigenetic changes that provide the cell with a survival advantage that promotes cellular immortality. Malignancy arises when tumors use mechanisms to evade detection and destruction by the immune system. Many malignancies seem to elicit an immune response, yet somehow manage to avoid destruction by the cells of the immune system. Cancers may evade this immune response by numerous mechanisms. Several targeted immune therapies are available that block some of these inhibitory signals and enhance the cell-mediated immune response. Many of these agents hold significant promise for future treatment of sinonasal and ventral skull base malignancies.

KW - Cell-mediated immunity

KW - Head and neck melanoma

KW - Head and neck squamous cell carcinoma

KW - Immunotherapy

KW - Mucosal melanoma

KW - Sinonasal malignancy

KW - Sinonasal tumors

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85015282497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015282497&partnerID=8YFLogxK

U2 - 10.1016/j.otc.2016.12.016

DO - 10.1016/j.otc.2016.12.016

M3 - Review article

C2 - 28314406

AN - SCOPUS:85015282497

VL - 50

SP - 443

EP - 455

JO - Otolaryngologic Clinics of North America

JF - Otolaryngologic Clinics of North America

SN - 0030-6665

IS - 2

ER -